Cefpodoxime 100 mg + Potassium Clavulanate 62.5 mg Film-Coated Tablet

Cefpodoxime 100 mg + Potassium Clavulanate 62.5 mg Film-Coated Tablet is a film-coated tablet formulated with Cefpodoxime 100 mg + Potassium Clavulanate 62.5 mg. The active ingredient profile is Cefpodoxime; Potassium Clavulanate, placing the product in the cephalosporin + beta-lactamase inhibitor combination category. Cefpodoxime provides cephalosporin antibacterial activity, while clavulanate acts as a beta-lactamase inhibitor to help protect the antibiotic from certain resistance enzymes. The film coating provides a finished oral solid-dosage presentation and may help with handling and product acceptability. For website cataloguing, the composition, strength, dosage form and release/coating characteristics should be displayed prominently and consistently. This product is intended for professional pharmaceutical presentation and should not be described using unapproved efficacy, cure or superiority claims. Clinical selection should depend on the patient, diagnosis, susceptibility or symptom profile, and the prescriber’s judgement. Prescription status, contraindications, precautions, interactions, adverse-effect information and dosing must be checked against the current approved label before publication. Manufacturer, licence, storage, shelf-life, pack configuration and market-specific regulatory details should be added only from verified product documentation.